Capecitabine-Based Chemoendocrine Combination as First-Line Treatment for Metastatic Hormone-Positive Metastatic Breast Cancer: Phase 2 Study
2020 ◽
Vol 20
(3)
◽
pp. 228-237
◽
Keyword(s):
Phase 2
◽
2018 ◽
Vol 174
(2)
◽
pp. 433-442
◽